Sales revenues for June 2018

Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for June 2018 the Company recorded a decrease of sales revenues of 22% compared to the same month of 2017, including 2% decrease of domestic sales and a decrease of 34% of export sales.

For the first six months of this year, revenues from sales of products decreased by 8% compared to the same period of 2017, including 6% decrease of domestic sales and 10% decrease of export sales.